Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

University of New Mexico

Quality Improvement/Patient Safety Symposium

2020

Articles 1 - 1 of 1

Full-Text Articles in Medicine and Health Sciences

Continuation Of Midodrine Upon Icu Discharge, Fahad Hussain, Deepti S. Rao Jan 2020

Continuation Of Midodrine Upon Icu Discharge, Fahad Hussain, Deepti S. Rao

Quality Improvement/Patient Safety Symposium

Indications for Continuation of Alpha-1 Agonist Midodrine Upon ICU Discharge

Hussain, Fahad, MSII; Rao, Deepti, MD

Introduction:

Persistent hypotension in patients affected by circulatory shock is a common barrier to discharge in the ICU. Even after these patients have been otherwise stabilized, low-level hypotension often ensures that they remain in the ICU on IV vasopressors. Midodrine, an oral α1-agonist, has shown promise as an adjunct therapy to wean patients off IV vasopressors and facilitate earlier discharge from the ICU. According to a recent study done at the Mayo Clinic ICU, Rochester, discharge on Midodrine was associated with a shorter ICU …